000 | 01010 a2200277 4500 | ||
---|---|---|---|
005 | 20250518054129.0 | ||
264 | 0 | _c20200330 | |
008 | 202003s 0 0 eng d | ||
022 | _a1365-2036 | ||
024 | 7 |
_a10.1111/apt.15434 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRühlemann, Malte | |
245 | 0 | 0 |
_aEditorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Authors' reply. _h[electronic resource] |
260 |
_bAlimentary pharmacology & therapeutics _c09 2019 |
||
300 |
_a606-607 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aCholangitis, Sclerosing |
650 | 0 | 4 | _aColitis |
650 | 0 | 4 | _aFeces |
650 | 0 | 4 | _aGastrointestinal Microbiome |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMicrobiota |
700 | 1 | _aFranke, Andre | |
773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 50 _gno. 5 _gp. 606-607 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.15434 _zAvailable from publisher's website |
999 |
_c30007413 _d30007413 |